Invention Grant
US08389537B2 Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
有权
4-甲基N- [3-（4-甲基 - 咪唑-1-基）-5-三氟甲基 - 苯基] -3-（4-吡啶-3-基 - 嘧啶-2-基氨基） - 苯甲酰胺
![Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide](/docs/US/2013-03-05/US08389537B2/abs.jpg.600x600.jpg)
- Patent Title: Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
- Patent Title (中): 4-甲基N- [3-（4-甲基 - 咪唑-1-基）-5-三氟甲基 - 苯基] -3-（4-吡啶-3-基 - 嘧啶-2-基氨基） - 苯甲酰胺
-
Application No.: US13419132Application Date: 2012-03-13
-
Publication No.: US08389537B2Publication Date: 2013-03-05
- Inventor: Paul W Manley , Wen-Chung Shieh , Paul Allen Sutton , Piotr H Karpinski , Raeann Wu , Stéphanie Monnier , Jörg Brozio
- Applicant: Paul W Manley , Wen-Chung Shieh , Paul Allen Sutton , Piotr H Karpinski , Raeann Wu , Stéphanie Monnier , Jörg Brozio
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Stephen Johnson
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61P35/00 ; C07D401/14
![Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide](/abs-image/US/2013/03/05/US08389537B2/abs.jpg.150x150.jpg)
Abstract:
Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide are prepared by various processes.
Public/Granted literature
Information query
IPC分类:
